1. Home
  2. EXEL vs GL Comparison

EXEL vs GL Comparison

Compare EXEL & GL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exelixis Inc.

EXEL

Exelixis Inc.

HOLD

Current Price

$43.72

Market Cap

11.4B

Sector

Health Care

ML Signal

HOLD

Logo Globe Life Inc.

GL

Globe Life Inc.

HOLD

Current Price

$153.04

Market Cap

10.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXEL
GL
Founded
1994
1900
Country
United States
United States
Employees
N/A
3695
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Life Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
11.4B
10.7B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
EXEL
GL
Price
$43.72
$153.04
Analyst Decision
Buy
Buy
Analyst Count
21
11
Target Price
$46.50
$167.27
AVG Volume (30 Days)
2.1M
419.3K
Earning Date
05-05-2026
04-22-2026
Dividend Yield
N/A
0.71%
EPS Growth
57.95
N/A
EPS
2.78
N/A
Revenue
$452,477,000.00
N/A
Revenue This Year
$13.61
$9.64
Revenue Next Year
$13.13
$5.61
P/E Ratio
$16.05
$10.21
Revenue Growth
N/A
N/A
52 Week Low
$33.76
$116.73
52 Week High
$48.74
$155.08

Technical Indicators

Market Signals
Indicator
EXEL
GL
Relative Strength Index (RSI) 46.95 65.07
Support Level $43.53 $135.08
Resistance Level $44.32 $153.90
Average True Range (ATR) 1.34 3.04
MACD -0.20 0.12
Stochastic Oscillator 5.54 78.99

Price Performance

Historical Comparison
EXEL
GL

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

Share on Social Networks: